Literature DB >> 18218634

Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect.

Lu Gao1, Mark Nils Hanson, Mini Balakrishnan, Paul L Boyer, Bernard P Roques, Stephen H Hughes, Baek Kim, Robert A Bambara.   

Abstract

The 2',3'-dideoxy-3'-thiacytidine drug-resistant M184I HIV-1 reverse transcriptase (RT) has been shown to synthesize DNA with decreased processivity compared with the wild-type RT. M184A displays an even more severe processivity defect. However, the basis of this decreased processivity has been unclear, and both primer-template binding and dNTP interaction defects have been proposed to account for it. In this study, we show that the altered properties of the M184I and M184A RT mutants that we have measured, including decreased processivity, a slower rate of primer extension, and increased strand transfer activity, can all be explained by a defect in dNTP utilization. These alterations are observed only at low dNTP concentration and vanish as the dNTP concentration is raised. The mutant RTs exhibit a normal dissociation rate from a DNA primer-RNA template while paused during synthesis. Slower than normal synthesis at physiological dNTP concentration, coupled with normal dissociation from the primer-template, results in the lowered processivity. The mutant RTs exhibit normal DNA 3'-end-directed and RNA 5'-end-directed ribonuclease H activity. The reduced rate of DNA synthesis causes an increase in the ratio of ribonuclease H to polymerase activity thereby promoting increased strand transfer. These latter results are consistent with an observed higher rate of recombination by HIV-1 strains with Met-184 mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218634      PMCID: PMC2431043          DOI: 10.1074/jbc.M710148200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Retroviral recombination during reverse transcription.

Authors:  D W Goodrich; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function.

Authors:  N Tanese; A Telesnitsky; S P Goff
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination.

Authors:  W S Hu; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  On the processive mechanism of Escherichia coli DNA polymerase I. Quantitative assessment of processivity.

Authors:  R A Bambara; D Uyemura; T Choi
Journal:  J Biol Chem       Date:  1978-01-25       Impact factor: 5.157

5.  Genetic recombination of human immunodeficiency virus.

Authors:  F Clavel; M D Hoggan; R L Willey; K Strebel; M A Martin; R Repaske
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

6.  Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.

Authors:  M Tisdale; S D Kemp; N R Parry; B A Larder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  Requirements for strand transfer between internal regions of heteropolymer templates by human immunodeficiency virus reverse transcriptase.

Authors:  J J DeStefano; L M Mallaber; L Rodriguez-Rodriguez; P J Fay; R A Bambara
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  First large scale chemical synthesis of the 72 amino acid HIV-1 nucleocapsid protein NCp7 in an active form.

Authors:  H de Rocquigny; D Ficheux; C Gabus; M C Fournié-Zaluski; J L Darlix; B P Roques
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

9.  Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage.

Authors:  Varuni K Jamburuthugoda; Jose M Santos-Velazquez; Mark Skasko; Darwin J Operario; Vandana Purohit; Pauline Chugh; Erika A Szymanski; Joseph E Wedekind; Robert A Bambara; Baek Kim
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

10.  Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.

Authors:  O Poch; I Sauvaget; M Delarue; N Tordo
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  25 in total

Review 1.  The high cost of fidelity.

Authors:  Sarah B Lloyd; Stephen J Kent; Wendy R Winnall
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01       Impact factor: 2.205

2.  A role of template cleavage in reduced excision of chain-terminating nucleotides by human immunodeficiency virus type 1 reverse transcriptase containing the M184V mutation.

Authors:  Antonio J Acosta-Hoyos; Suzanne E Matsuura; Peter R Meyer; Walter A Scott
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Selective modification of adenovirus replication can be achieved through rational mutagenesis of the adenovirus type 5 DNA polymerase.

Authors:  Cristina Capella; Michael-John Beltejar; Caitlin Brown; Vincent Fong; Waaqo Daddacha; Baek Kim; Stephen Dewhurst
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

4.  Subunit-selective mutational analysis and tissue culture evaluations of the interactions of the E138K and M184I mutations in HIV-1 reverse transcriptase.

Authors:  Hong-Tao Xu; Maureen Oliveira; Peter K Quashie; Matthew McCallum; Yingshan Han; Yudong Quan; Bluma G Brenner; Mark A Wainberg
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

5.  Host SAMHD1 protein promotes HIV-1 recombination in macrophages.

Authors:  Laura A Nguyen; Dong-Hyun Kim; Michele B Daly; Kevin C Allan; Baek Kim
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

6.  Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors.

Authors:  Hong-Tao Xu; Susan P Colby-Germinario; Maureen Oliveira; Daniel Rajotte; Richard Bethell; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

7.  Altered strand transfer activity of a multiple-drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutant with a dipeptide fingers domain insertion.

Authors:  Laura A Nguyen; Waaqo Daddacha; Sean Rigby; Robert A Bambara; Baek Kim
Journal:  J Mol Biol       Date:  2011-11-12       Impact factor: 5.469

8.  Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1.

Authors:  Alonso Heredia; Charles Davis; Mohammed N Amin; Nhut M Le; Mark A Wainberg; Maureen Oliveira; Steven G Deeks; Lai-Xi Wang; Robert R Redfield
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

9.  Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine.

Authors:  Hong-Tao Xu; Susan P Colby-Germinario; Eugene L Asahchop; Maureen Oliveira; Matthew McCallum; Susan M Schader; Yingshan Han; Yudong Quan; Stefan G Sarafianos; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

10.  Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage.

Authors:  Varuni K Jamburuthugoda; Jose M Santos-Velazquez; Mark Skasko; Darwin J Operario; Vandana Purohit; Pauline Chugh; Erika A Szymanski; Joseph E Wedekind; Robert A Bambara; Baek Kim
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.